We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.

CENTRAL NERVOUS SYSTEM DISORDERS THERAPEUTICS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2021 - 2028)

Central Nervous System Disorders Therapeutics Market, by Disease Type (Neurodegenerative Disorders {Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, and Others}, Infectious Diseases, Psychotic Disorders, Anxiety Disorders, Trauma, Mood Disorders, and Others), by Drug Class (Analgesics, Anti-cholinergic Agents, Anticonvulsants, Sedatives and Hypnotics, Antidepressants, Antipsychotics, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

Published In: 29 Nov, 2021
Code: CMI4544
Page number: 192
Formats: Excel and PDF
Industry: Pharmaceutical

Table of Contents (Version-2026)

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Disease Type
  - Market Snapshot, By Drug Class
  - Market Snapshot, By Distribution Channel
  - Market Snapshot, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Opportunity
- Impact Analysis
- PEST Analysis
- Regulatory Scenario
- Market Trends
- Key Developments
- Pipeline Analysis
- Regulatory Scenario
- Epidemiology
- Prescription Pattern and Prescribing Behavior
Global Central Nervous System Disorders Therapeutics Market– Impact of Coronavirus (COVID-19) Pandemic
- Demand and Supply Analysis
- Epidemiology
- Government Initiatives
Global Central Nervous System Disorders Therapeutics Market,

By Disease Type, 2017 – 2028, (US$ Mn)
- Introduction
  - Market Share Analysis, 2021 and 2028 (%)
  - Y-o-Y Growth Analysis, 2018 – 2028
  - Segment Trends
- Neurodegenerative Disorders
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    - Alzheimer’s Disease
    - Parkinson’s Disease
    - Multiple Sclerosis
    - Others
- Infectious Diseases
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Psychiatric Disorders
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Anxiety Disorders
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    - Dry
    - Wet
- Trauma
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Mood Disorders
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
Global Central Nervous System Disorders Therapeutics Market, By Drug Class, 2017 – 2028, (US$ Mn)
- Introduction
  - Market Share Analysis, 2021 and 2028 (%)
  - Y-o-Y Growth Analysis, 2018 – 2028
  - Segment Trends
- Analgesics
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Anti-cholinergic Agents
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Anticonvulsants
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Sedatives and Hypnotics
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Antidepressants
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Antipsychotics
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
Global Central Nervous System Disorders Therapeutics Market, By Distribution Channel, 2017 – 2028, (US$ Mn)
- Introduction
  - Market Share Analysis, 2021 and 2028 (%)
  - Y-o-Y Growth Analysis, 2018 – 2028
  - Segment Trends
- Hospital Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Retail Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Online Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
Global Central Nervous System Disorders Therapeutics Market, By Region, 2017 – 2028, (US$ Mn)
- Introduction
  - Market Share Analysis, By Region, 2021 and 2028 (%)
  - Y-o-Y Growth Analysis, For Regions, 2017–2028
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2028, (US$ Mn)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2028, (US$ Mn)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2028, (US$ Mn)
    - U.K.
    - Germany
    - France
    - Italy
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2028, (US$ Mn)
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2028, (US$ Mn)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Mn)
  - Market Size and Forecast, and Y-o-Y Growth, By Region/Country, 2017 – 2028, (US$ Mn)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
  - Biogen Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Pfizer Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Eli Lilly and Company
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Merck & Co., Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Novartis AG
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - AstraZeneca Plc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Teva Pharmaceutical Industries Ltd.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Takeda Pharmaceutical Company Limited
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - AbbVie Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Glaxosmithkline plc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Otsuka Pharmaceutical Co., Ltd.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Reddy's Laboratories Ltd.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Cipla Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Lupin Ltd
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
  - Glenmark Pharmaceuticals
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Strategies
- Analyst Views
Section
- Research Methodology
- About us

*Browse 36 market data tables and 43 figures on "Central Nervous System Disorders Therapeutics Market” - Global forecast to 2028

Get Instant Access - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now